Best Practice & Research Clinical Haematology
Volume 21, Issue 4 , Pages 677-682, December 2008

Advances in the clinical management of GVHD

  • James L.M. Ferrara, MD (Director)

      Affiliations

    • Corresponding Author InformationDepartments of Pediatrics and of Internal Medicine, the University of Michigan Medical School, Comprehensive Cancer Center, 1500 E. Medical Center Drive, SPC 5942, Room 6308, Ann Arbor, MI 48109-5942, USA. Tel.: +1 734 615 1340; Fax: +1 734 615 3947.

Blood & Marrow Transplant Program, The University of Michigan Comprehensive Cancer Center, 1500 E. Medical Center Drive, SPC 5942, Room 6308, Ann Arbor, MI48109-5942, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(08)00059-5

doi:10.1016/j.beha.2008.07.003

Best Practice & Research Clinical Haematology
Volume 21, Issue 4 , Pages 677-682, December 2008

Article Tools

* Image Usage & Resolution